Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 11/20 | 0.88 |
| ▸ | CNR1 | P21554 | 8/20 | 0.88 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14746929 | 0.93 | CNR2 (0.81) | CNR2CNR1TDP1 | |
| SCHEMBL29549705 | 0.90 | CNR2 (1.00) | CNR2CNR1TDP1 | |
| SCHEMBL674289 | 0.90 | CNR2 (1.00) | CNR2CNR1TDP1 | |
| SCHEMBL30472028 | 0.90 | CNR2 (1.00) | CNR2CNR1TDP1 | |
| SCHEMBL2186051 | 0.86 | CNR2 (0.68) | CNR2CNR1TDP1 | |
| SCHEMBL14746942 | 0.86 | CNR2 (0.88) | CNR2CNR1TDP1 | |
| SCHEMBL14746864 | 0.85 | CNR2 (0.86) | CNR2CNR1TDP1 | |
| SCHEMBL496427 | 0.84 | CNR2 (0.73) | CNR2CNR1 | |
| SCHEMBL496171 | 0.84 | CNR2 (0.73) | CNR2CNR1 | |
| SCHEMBL14746878 | 0.83 | CNR2 (0.82) | CNR2CNR1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100216785-A1 | PHARMACEUTICAL COMPOSITIONS | NEUROSCIENZE PHARMANESS S.C. A.R.L. (IT) | 2010-08-26 | — | — | US | disclosed |
| US-20100216785-A1 | PHARMACEUTICAL COMPOSITIONS | NEUROSCIENZE PHARMANESS S.C. A.R.L. (IT) | 2010-08-26 | — | — | US | disclosed |
| US-20100216785-A1 | PHARMACEUTICAL COMPOSITIONS | NEUROSCIENZE PHARMANESS S.C. A.R.L. (IT) | 2010-08-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100216785-A1 | PHARMACEUTICAL COMPOSITIONS | CNR2, CNR1, SGMS2 | CNR2 1/4885CNR1 2/4885TDP1 4784/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.